| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 01/27/2005 | WO2005007815A2 Hairpin-labeled probes and methods of use |
| 01/27/2005 | WO2005007814A2 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | WO2005007812A2 Genes as diagnostic tools for autism |
| 01/27/2005 | WO2005007811A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | WO2005007810A2 Functional synthetic molecules and macromolecules for gene delivery |
| 01/27/2005 | WO2005007808A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | WO2005007807A2 Dielectrophoresis apparatus |
| 01/27/2005 | WO2005007805A2 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 01/27/2005 | WO2005007802A2 Fibrous composite for tissue engineering |
| 01/27/2005 | WO2005007799A2 Methods for ex-vivo expanding stem/progenitor cells |
| 01/27/2005 | WO2005007798A2 Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione |
| 01/27/2005 | WO2005007797A2 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | WO2005007073A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 01/27/2005 | WO2004099371A3 Methods of treating ischemic related conditions |
| 01/27/2005 | WO2004072232A3 Covalent tethering of functional groups to proteins |
| 01/27/2005 | WO2004053090A3 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 01/27/2005 | WO2004039952A8 Methods of use for novel human polypeptides encoded by polynucleotides |
| 01/27/2005 | US20050022168 Method and system for detecting discriminatory data patterns in multiple sets of data |
| 01/27/2005 | US20050020682 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 01/27/2005 | US20050020550 Selective testicular 11beta-HSD inhibitors and methods of use thereof |
| 01/27/2005 | US20050019891 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 01/27/2005 | US20050019852 transforming the host cells to express a heterologous, codon-optimized gene encoding a carotene desaturase for the in vivo bioconversion of beta-carotene and/or gamma-carotene into isorenieratene, chlorobactene and/or beta-isorenieratene; Escherichia coli carotene desaturase gene |
| 01/27/2005 | US20050019846 Using ornithine carbamoyltransferase (OCT) as diagnostic tool in screening for antifungal agents; fungicides and disease resistant plants |
| 01/27/2005 | US20050019830 Methods of screening for TRPM5 modulators |
| 01/27/2005 | CA2533199A1 Reactive polymers and copolymers, method of their preparation and their use |
| 01/27/2005 | CA2532216A1 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | CA2532138A1 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | CA2531698A1 Method for assaying protein-protein interaction |
| 01/27/2005 | CA2531695A1 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 01/27/2005 | CA2531692A1 Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides |
| 01/27/2005 | CA2531560A1 Hairpin-labeled probes and methods of use |
| 01/27/2005 | CA2530810A1 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | CA2525825A1 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | CA2522508A1 Antisense antiviral agent and method for treating ssrna viral infection |
| 01/27/2005 | CA2516652A1 System for external control of oncolytic virus replication |
| 01/26/2005 | EP1446476A4 Endothelial cells derived from primate embryonic stem cells |
| 01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
| 01/26/2005 | CN1186447C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 01/26/2005 | CN1186446C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 01/20/2005 | WO2005005615A2 Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer |
| 01/20/2005 | WO2005005614A2 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| 01/20/2005 | WO2005005613A2 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein |
| 01/20/2005 | WO2005005612A2 Tag-1 and tag-2 proteins and uses thereof |
| 01/20/2005 | WO2005005611A2 Crystals and structures of protein kinase chk2 |
| 01/20/2005 | WO2005005610A2 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | WO2005005609A2 Multi-staged absorbable nonwoven structures for culturing pancreatic cells |
| 01/20/2005 | WO2005005608A2 Compositions and methods for differentiating adipose stromal cells into pancratic beta cells |
| 01/20/2005 | WO2005005607A2 Seeding pancreatic cells on porous matrices |
| 01/20/2005 | WO2005005606A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005005604A2 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 01/20/2005 | WO2005005603A2 Method for inducing an immune response to cancer antigen |
| 01/20/2005 | WO2005005602A2 Methods for the identification of inhibitors of fumarate reductase and vacuolar protein sorting-associated protein as antibiotics |
| 01/20/2005 | WO2005005601A2 Compositions and methods for treating and diagnosing cancer |
| 01/20/2005 | WO2005005599A2 Modulation of c-reactive protein expression |
| 01/20/2005 | WO2005005598A2 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 01/20/2005 | WO2005005597A2 Novel mouse polypeptides encode by polynucleotides and methods of their use |
| 01/20/2005 | WO2005005596A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | WO2004083382A3 Compositions and methods for treating hyperimmune response in the eye |
| 01/20/2005 | WO2004076648A9 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 01/20/2005 | WO2004063323A3 Aflp-based method for integrating physical and genetic maps |
| 01/20/2005 | WO2004043977A3 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| 01/20/2005 | WO2004024886A3 Microarray synthesis and assembly of gene-length polynucleotides |
| 01/20/2005 | US20050015821 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use |
| 01/20/2005 | US20050014713 Controlling gene expression;diagnosis, therapy of disease; antidiabetic agents; insulin resistance |
| 01/20/2005 | US20050014270 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014257 Modulation of C-reactive protein expression |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014196 Prion protein binding materials and methods of use |
| 01/20/2005 | US20050014140 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 01/20/2005 | US20050014098 Biocompatible resists |
| 01/20/2005 | CA2532196A1 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | CA2531482A1 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 01/20/2005 | CA2530182A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2528669A1 Compositions and methods for treating and diagnosing cancer |
| 01/20/2005 | CA2527537A1 Modulation of c-reactive protein expression |
| 01/19/2005 | EP1497438A1 Means and methods for the production of adenovirus vectors |
| 01/19/2005 | EP1497409A2 Growth medium for microorganisms comprising the biomass of methanotrophic bacteria |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/13/2005 | WO2005003372A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003325A2 Inhibition of viral pathogenesis |
| 01/13/2005 | WO2005003323A2 Use of calcium binding proteins to improve cardiac contractile function |
| 01/13/2005 | WO2005003322A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | WO2005003321A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | WO2005003319A2 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/13/2005 | WO2005003318A2 Assay and process for labeling and detection of micro rna and small interfering rna sequences |
| 01/13/2005 | WO2005003317A2 Engineered blood vessels |
| 01/13/2005 | WO2005003316A2 Rna processing protein complexes and uses thereof |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005003314A2 A method of selecting an active oligonucleotide predictive model |
| 01/13/2005 | WO2005003313A2 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | WO2005003310A2 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| 01/13/2005 | WO2005003309A2 Pseudopterosin production |
| 01/13/2005 | WO2005003308A2 Biological data set comparison method |
| 01/13/2005 | WO2005003307A2 Compositions and methods for analysis and manipulation of enzymes in biosynthetic proteomes |
| 01/13/2005 | WO2005003306A2 Sppls as modifiers of the p53 pathway and methods of use |
| 01/13/2005 | WO2005003305A2 Usps as modifiers of the beta catenin pathway and methods of use |